| DAY 3 - Sunday, 26 October 2025 | ||||
| 09.00 - 11.00 MAIN HALL Chairs: Aliya Khan, Alper Gürlek |
||||
| 09.00 - 09.30 | Fracture Risk Assessment and FRAX: limitations and advantages – John Carey |
|||
| 09.30 - 10.00 | X-Linked hypophosphatemia - evaluation and management – Aliya Khan |
|||
| 10.00 - 10.30 | MEN and Parathyroid disease - screening, diagnosis and management – Maria Luisa Brandi | |||
| 10.30 - 11.00 | Hypoparathyroidism - Advances in diagnosis and management – Heide Siggelkow |
|||
| 11.00 - 11.20 | Coffee Break | |||
| 11.20 - 13.20 MAIN HALL Barbara McGowan, Dilek Yazıcı |
 |
|||
| 11.20 - 11.50 | Role of genetic/epigenetic factors on the risk for obesity and treatment response – Gema Frühbeck | |||
| 11.50 - 12.20 | Exercise physiology and obesity – Andreea Ciudin | |||
| 12.20 - 12.50 | The evolving landscape of OMM: single, dual, triple agonists and their impact in obesity complications – Barbara McGowan | |||
| 12.50 - 13.20 | Update on lipid management – Dipesh Patel |
|||
| 13.20 - 13.30 | Closing comments and adjourn | |||